2011
Granulicatella adiacens and Early-Onset Sepsis in Neonate - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC
Bizzarro MJ, Callan DA, Farrel PA, Dembry LM, Gallagher PG. Granulicatella adiacens and Early-Onset Sepsis in Neonate - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2011, 17: 1971-1973. PMID: 22000391, PMCID: PMC3310662, DOI: 10.3201/eid1710.101967.Peer-Reviewed Original Research
2007
Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unit
Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unit. Archives Of Disease In Childhood Fetal & Neonatal 2007, 92: f120. PMID: 17088342, PMCID: PMC2675455, DOI: 10.1136/adc.2006.102855.Peer-Reviewed Original ResearchMeSH KeywordsBacteremiaBirth WeightCase-Control StudiesConnecticutCross InfectionDrug Resistance, BacterialEndemic DiseasesEscherichia coliEscherichia coli InfectionsFemaleHumansInfant, NewbornIntensive Care Units, NeonatalMaleMicrobial Sensitivity TestsPrognosisRisk FactorsSerratia InfectionsSerratia marcescensConceptsNeonatal intensive care unitIntensive care unitCare unitUninfected controlsHospital Neonatal Intensive Care UnitSerratia marcescens bacteremiaMedian gestational ageCentral vascular catheterEscherichia coli bacteremiaRecords of infantsCase-control studyHigher overall mortalityE coliOnset of infectionCase-control analysisTime of infectionHigh rateAssociated meningitisHospital courseColi bacteremiaOverall mortalityGestational agePremature infantsVascular cathetersBirth weight
2003
Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections
Bassetti M, Farrel PA, Callan DA, Topal JE, Dembry LM. Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections. International Journal Of Antimicrobial Agents 2003, 21: 593-594. PMID: 12791477, DOI: 10.1016/s0924-8579(03)00090-6.Peer-Reviewed Original Research
2002
Antimicrobial Activities of BMS-284756 Compared with Those of Fluoroquinolones and β-Lactams against Gram-Positive Clinical Isolates
Bassetti M, Dembry L, Farrel P, Callan D, Andriole V. Antimicrobial Activities of BMS-284756 Compared with Those of Fluoroquinolones and β-Lactams against Gram-Positive Clinical Isolates. Antimicrobial Agents And Chemotherapy 2002, 46: 234-238. PMID: 11751142, PMCID: PMC126992, DOI: 10.1128/aac.46.1.234-238.2002.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsAnti-Infective AgentsBeta-LactamsFluoroquinolonesGram-Positive BacteriaHumansIndolesMicrobial Sensitivity TestsQuinolonesConceptsBMS-284756Clinical isolatesGram-positive clinical isolatesResistant coagulase-negative staphylococciBeta-hemolytic streptococciAmoxicillin-clavulanic acidPositive clinical isolatesResistant Staphylococcus aureusCoagulase-negative staphylococciPiperacillin-tazobactamStreptococcus viridansStreptococcus pneumoniaeStaphylococcus aureusΒ-lactamsActive agentsIsolatesCeftriaxoneAntibacterial activityImipenemMoxifloxacinPneumoniaeViridansFluoroquinolones
2001
Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria
Bassetti M, Dembry L, Farrel P, Callan D, Andriole V. Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria. Diagnostic Microbiology And Infectious Disease 2001, 41: 143-148. PMID: 11750168, DOI: 10.1016/s0732-8893(01)00298-x.Peer-Reviewed Original ResearchConceptsAmoxicillin/clavulanic acidPiperacillin/tazobactamClavulanic acidMethicillin-susceptible S. aureusPenicillin-nonsusceptible Streptococcus pneumoniaeMethicillin-sensitive S. epidermidisMethicillin-resistant coagulase-negative staphylococciGram-positive infectionsViridans group streptococciCoagulase-negative staphylococciPromising new fluoroquinoloneActive agentsNew fluoroquinoloneStreptococcal isolatesGroup streptococciVitro antibacterial activityClinical isolatesStreptococcus pneumoniaeComparative antimicrobial activityStaphylococcal isolatesClinical useEnterococcal isolatesImipenemGatifloxacinE. faecalis
2000
Molecular Typing Demonstrating Transmission of Gram-Negative Rods in a Neonatal Intensive Care Unit in the Absence of a Recognized Epidemic
Almuneef M, Baltimore R, Farrel P, Reagan-Cirincione P, Dembry L. Molecular Typing Demonstrating Transmission of Gram-Negative Rods in a Neonatal Intensive Care Unit in the Absence of a Recognized Epidemic. Clinical Infectious Diseases 2000, 32: 220-227. PMID: 11170911, DOI: 10.1086/318477.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsBacterial Typing TechniquesCross InfectionDNA, BacterialDrug Resistance, MicrobialElectrophoresisFecesFemaleGenotypeGentamicinsGram-Negative Aerobic Rods and CocciGram-Negative Bacterial InfectionsHumansInfantInfant, NewbornIntensive Care Units, NeonatalMaleMicrobial Sensitivity TestsConceptsNeonatal intensive care unitIntensive care unitShared strainsCare unitMolecular typing techniquesRectal swab culturesColonization of infantsGentamicin-resistant strainsWeeks of ageTyping techniquesAntibiotic treatmentAntibiotic useSwab culturesGram-negative rodsGentamicin susceptibilityInfantsTotal daysOutbreak investigationIdentical strainsNegative rodsUnique strainsHigh rateContour-clamped homogeneous electric field electrophoresisAdmissionGentamicin
1998
Comparison of In Vitro Activity of Trovafloxacin Against Gram-positive and Gram-negative Organisms with Quinolones and β-Lactam Antimicrobial Agents
Dembry L, Roberts J, Schock K, Marino S, Farrel P, Andriole V. Comparison of In Vitro Activity of Trovafloxacin Against Gram-positive and Gram-negative Organisms with Quinolones and β-Lactam Antimicrobial Agents. Diagnostic Microbiology And Infectious Disease 1998, 31: 301-311. PMID: 9597391, DOI: 10.1016/s0732-8893(98)00004-2.Peer-Reviewed Original Research
1997
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Dembry LM, Farrel PA, Orcutt DR, Gerrity LA, Andriole VT. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest. Journal Of Antimicrobial Chemotherapy 1997, 39: 35-42. PMID: 9222068, DOI: 10.1093/jac/39.suppl_2.35.Peer-Reviewed Original ResearchConceptsActivity of trovafloxacinCombination of trovafloxacinAmpicillin/sulbactamMicrodilution broth methodBroth methodCombination of ciprofloxacinEnterococcus faecium isolatesGram-negative organismsGram-positive organismsAntibiotic combinationsEnterococcus faecalis isolatesActive agentsFaecium isolatesTrovafloxacinComparison of MICsIndifferent effectStandard microdilution broth methodFaecalis isolatesGentamicinMorganella morganiiCiprofloxacinProteus mirabilisEtestSulbactamStenotrophomonas maltophilia